1dyr: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
Line 1: Line 1:
[[Image:1dyr.gif|left|200px]]
{{Seed}}
[[Image:1dyr.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1dyr|  PDB=1dyr  |  SCENE=  }}  
{{STRUCTURE_1dyr|  PDB=1dyr  |  SCENE=  }}  


'''THE STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TO 1.9 ANGSTROMS RESOLUTION'''
===THE STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TO 1.9 ANGSTROMS RESOLUTION===




==Overview==
<!--
BACKGROUND: The fungal pathogen Pneumocystis carinii causes a pneumonia which is an opportunistic infection of AIDS patients. Current therapy includes the dihydrofolate reductase (DHFR) inhibitor trimethoprim which is selective but only a relatively weak inhibitor of the enzyme for P. carinii. Determination of the three-dimensional structure of the enzyme should form the basis for design of more potent and selective therapeutic agents for treatment of the disease. RESULTS: The structure of P. carinii DHFR in complex with reduced nicotinamide adenine dinucleotide phosphate and trimethoprim has accordingly been solved by X-ray crystallography. The structure of the ternary complex has been refined at 1.86 A resolution (R = 0.181). A similar ternary complex with piritrexim (which is a tighter binding, but less selective inhibitor) has also been solved, as has the binary complex holoenzyme, both at 2.5 A resolution. CONCLUSIONS: These structures show how two drugs interact with a fungal DHFR. A comparison of the three-dimensional structure of this relatively large DHFR with bacterial or mammalian enzyme-inhibitor complexes determined previously highlights some additional secondary structure elements in this particular enzyme species. These comparisons provide further insight into the principles governing DHFR-inhibitor interaction, in which the volume of the active site appears to determine the strength of inhibitor binding.
The line below this paragraph, {{ABSTRACT_PUBMED_7866743}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 7866743 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_7866743}}


==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Stammers, D K.]]
[[Category: Stammers, D K.]]
[[Category: Oxido-reductase]]
[[Category: Oxido-reductase]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 14:26:44 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 23:49:30 2008''

Revision as of 20:49, 30 June 2008

File:1dyr.png

Template:STRUCTURE 1dyr

THE STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TO 1.9 ANGSTROMS RESOLUTION

Template:ABSTRACT PUBMED 7866743

About this Structure

1DYR is a Single protein structure of sequence from Pneumocystis carinii. Full crystallographic information is available from OCA.

Reference

The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution., Champness JN, Achari A, Ballantine SP, Bryant PK, Delves CJ, Stammers DK, Structure. 1994 Oct 15;2(10):915-24. PMID:7866743

Page seeded by OCA on Mon Jun 30 23:49:30 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=1dyr&oldid=589822"